Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor

Safe and effective prophylactic vaccines are urgently needed to contain the coronavirus disease 2019 (COVID-19) pandemic. However, several vaccination-related adverse effects have been reported. Here, we report a rare case of severe immune thrombocytopenia occurring 3 days after receiving the mRNA-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Kah-Meng, Yang, Ching-Yao, Lin, Chien-Chin, Lien, Wan-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932008/
https://www.ncbi.nlm.nih.gov/pubmed/35339338
http://dx.doi.org/10.1016/j.ajem.2022.03.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932008/
https://www.ncbi.nlm.nih.gov/pubmed/35339338
http://dx.doi.org/10.1016/j.ajem.2022.03.030

Ejemplares similares